The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...
Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
The FDA was scheduled to release its decision on Novavax’s updated, protein-based COVID-19 vaccine on April 1.
Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary ...
The US drug regulator has missed a deadline for granting full approval to Novavax's COVID-19 vaccine, the company said ...
The Trump administration carved out an exception for pharmaceuticals from the president's new tariff regime, at least for now ...
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...